These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1695 related items for PubMed ID: 11759218

  • 1. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N.
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [Abstract] [Full Text] [Related]

  • 2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 3. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 4. Management of renal anemia.
    Peco-Antic A.
    Turk J Pediatr; 2005 Mar; 47 Suppl():19-27. PubMed ID: 15884663
    [Abstract] [Full Text] [Related]

  • 5. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC, Lai YH, Tsai ZY, Chien LJ, Tsai JH.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [Abstract] [Full Text] [Related]

  • 11. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Mar; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathophysiology of renal anemia.
    Eckardt KU.
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S2-8. PubMed ID: 10746799
    [Abstract] [Full Text] [Related]

  • 15. [Anemia in chronic renal insufficiency--case report].
    Popović M.
    Med Pregl; 1999 Feb; 52(6-8):279-81. PubMed ID: 10518388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
    Orlic L, Mikolasevic I, Lukenda V, Racki S, Stimac D, Milic S.
    Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.